RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0042-1750014
Hypertrophic Pachymeningitis Presenting as “Eyebrows” Sign on 18F FDG PET/CT
Funding None.
Abstract
Hypertrophic pachymeningitis refers to linear or nodular thickening of the dura mater covering the brain and spinal cord following various inflammatory/infective processes. Usually, magnetic resonance imaging brain shows uniform thickening with enhancement of involved meninges. Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) findings of pachymeningitis are rarely reported in literature. We describe the PET/CT findings of a patient with hypertrophic pachymeningitis involving the bilateral supraorbital regions depicting as “eyebrows” on brain maximum intensity projection image.
Patient's Consent
The authors certify that appropriate patient consent was obtained from the patient for publishing the images and clinical information in the journal without revealing patient identity.
Publikationsverlauf
Artikel online veröffentlicht:
16. August 2022
© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Goyal M, Sharma A, Mishra NK, Gaikwad SB, Sharma MC. Imaging appearance of pachymeningeal tuberculosis. AJR Am J Roentgenol 1997; 169 (05) 1421-1424
- 2 Thurtell MJ, Keed AB, Yan M, Gottlieb T, Spies JM, Halmagyi GM. Tuberculous cranial pachymeningitis. Neurology 2007; 68 (04) 298-300
- 3 Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ. Idiopathic hypertrophic pachymeningitis. Neurology 2004; 62 (05) 686-694
- 4 Akahoshi M, Yoshimoto G, Nakashima H. et al. MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod Rheumatol 2004; 14 (02) 179-183
- 5 De Virgilio A, de Vincentiis M, Inghilleri M. et al. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res 2017; 65 (01) 386-394
- 6 Higgins WL, Marano GD. Gallium imaging of rheumatoid pachymeningitis. Clin Nucl Med 1986; 11 (05) 350-351
- 7 Murai H, Kira J, Kobayashi T, Goto I, Inoue H, Hasuo K. Hypertrophic cranial pachymeningitis due to Aspergillus flavus. Clin Neurol Neurosurg 1992; 94 (03) 247-250
- 8 Boers J, Schröder CP, Hospers GAP, de Vries EFJ, Glaudemans AWJM. Detection of dural metastases before the onset of clinical symptoms by 16α-[18F]Fluoro-17β-estradiol PET in a patient with estrogen receptor-positive breast cancer. Clin Nucl Med 2021; 46 (03) e165-e167
- 9 Wong VC, Yung G, Russo R, Reddel SW, Mansberg R. Pachymeningitis demonstrated on gallium SPECT/CT scan. Clin Nucl Med 2019; 44 (04) 305-309
- 10 Chu KH, Lin YT, Hsu CC, Chen CY, Pan LK. Evaluation of effective dose for a patient under Ga-67 nuclear examination using TLD, water phantom and a simplified model. J Radiat Res (Tokyo) 2012; 53 (06) 989-998